<?xml version="1.0" encoding="UTF-8"?>
<p>All patients with ongoing intravenous drug use were informed about harm-reduction measures and prevention of HCV transmission and reinfection upon each visit at the low-threshold facility (e.g. needle and syringe exchange programs).</p>
